Minner, Sarah <br/><br/>
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2010 
 - 1553-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-2546  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Gene Amplification<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--genetics<br/>Prognosis<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--genetics<br/>Receptor, ErbB-2--biosynthesis<br/>Tissue Array Analysis<br/>Up-Regulation